ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis.

导出 OA

翻译打印收藏纠错

作者： Andrea,Duminuco ^[1] ; Helen T,Chifotides ^[2] ; Sebastiano,Giallongo ^[3] ; Cesarina,Giallongo ^[3] ; Daniele,Tibullo ^[4] ; Giuseppe A,Palumbo ^[1]

作者单位： Hematology Unit with BMT, A.O.U. Policlinico "G.Rodolico-San Marco", 95123 Catania, Italy. ^[1] Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1400 Holcombe Blvd., Houston, TX 77030, USA. ^[2] Department of Medical, Surgical Sciences and Advanced Technologies "G.F. Ingrassia", University of Catania, 95123 Catania, Italy. ^[3] Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy. ^[4]

关键词 ACVR1 ACVR1 inhibitor JAK inhibitor anemia hepcidin momelotinib myelofibrosis myeloproliferative neoplasms pacritinib ruxolitinib

DOI 10.3390/cancers16010154

PMID 38201581

发布时间 2024-02-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交